OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Succe... (r and better absorbed by the body compar...)

OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories

Date:9/12/2012

r and better absorbed by the body compared with conventional tablets.

FoetoH, Best Emerging Medtech

Award Presented by Team Consulting

FoetoH is a new portable technology for the care of babies before they are born. FoetoH targets foetal health and helps prevent stillbirths by providing a better quality and frequency of foetal monitoring anytime, anywhere and by anyone.

PsiOxus Therapeutics, Best Biotech Fundraiser

Award Presented by Pivotal Scientific

In July 2012, PsiOxus Therapeutics announced its closing of a Series B round of equity financing totalling £22 million, including investments from investors Imperial Innovations Invesco Perpetual, SR One and Lundbeckfond Ventures. The financing round will enable PsiOxus to advance the clinical development of ColoAd1, a systemically available oncolytic vaccine for the treatment of colorectal cancer.

Oxford Nanopore Technologies, Best Medtech Fundraiser

Award Presented by Milton Park

Oxford Nanopore is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores. The modular, scalable technology platform and miniaturised instrument are designed to offer substantial benefits in a variety of applications including DNA and protein sequencing. In May 2012, Oxford Nanopore announced a further fundraising of £31.4 million making them the largest disclosed fundraiser in the cluster this year.

EUSA Pharma, Best Biotech Dealmaker

Award Presented by Manches

In June 2012, EUSA Pharma was acquired by Jazz Pharmaceuticals for $680 million. The acquisition brings a portfolio of seven products including a significant new specialty product to the Jazz Pharmaceuticals U.S. portfolio including Erwinaze™ (asparaginase Erwiniachrysanthemi), a life-saving treatment for patients with acute ly
'/>"/>

SOURCE OBN
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Neuralstem President And CEO To Present At The 2012 Rodman & Renshaw Annual Healthcare Conference
2. Heart Failure Society of America Annual Meeting To Feature Several Satellite Symposia
3. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
4. Grifols Awards Winners of the 9th Annual eALTA Research Fellowship at 2012 ERS Meeting
5. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
6. Discuss Early Results of the DIAN Trial at CBIs 6th Annual Alzheimers Drug Development Summit
7. CBIs 9th Annual Forum on Formulary and Reimbursement Strategies: Payer Perspectives
8. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
9. Organogenesis Announces Annual College Scholarship Award Winner
10. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
11. New Annual US$3 Million Fundamental Physics Prize Recognizes Transformative Advances in the Field

Post Your Comments:

(Date:6/20/2013)... (PRWEB) June 20, 2013 Conscires offer ... levels of interests and budgets., , ... on Scrum basics and the ScrumMaster role. In addition ... group activities and discussions on the necessary soft skills ... Scrum Team, and company-oriented Scrum implementation aspects. , ...

(Date:6/19/2013)... , June 19, 2013 U.S. Secretary of State ... at which distinguished Syngenta scientist Mary-Dell Chilton ... 2013 World Food Prize. The prize is the foremost ... by improving the quality, quantity or availability of food ... other laureates were recognized for "revolutionary biotechnology discoveries that ...

(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...

Breaking Biology Technology:Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices 2 Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2 Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2 Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2 Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3

[0] Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices [0] Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate [0] Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System [0] Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

... ST. LOUIS, Oct. 5 ISTO Technologies, Inc. (ISTO), ... regeneration, announced today the completion of patient enrollment in ... an injectable formulation of juvenile chondrocytes designed for the ... patients enrolled at two clinical sites. All patients enrolled ...

... Lake, N.Y. Given the many pressing concerns of the ... to lose sleep. But for those whose responsibility it is ... charged with that mission include scientists like medical researcher Steve ... develop a vaccine that will protect the public against weaponized ...

... (Nasdaq: AMGN ) today announced that results ... trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX ... metastatic colorectal cancer (mCRC), respectively, were published online in ... "Both studies demonstrated that Vectibix administered with chemotherapy ...

ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial Plague researchers race to beat bioterrorists Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology

(Date:6/19/2013)... In the cover story for the journal ... at the University of Massachusetts Amherst describe a new ... study the function of individual proteins in individual cell ... should allow deeper insights into protein function, Chase says, ... what that single protein does when we isolate its ...

(Date:6/19/2013)... International Science Consortium (PISC) is extremely disappointed that ... has upheld a decision that requires Dow Benelux ... rats. The study will use approximately 1160 animals ... to the substance dipropylene glycol methyl ether acetate ... Community,s Regulation on the Registration, Evaluation, Authorisation and ...

(Date:6/19/2013)... Diversity Course at the Marine Biological Laboratory (MBL), ... in Microbiology site by the American Society for ... program recognizes institutions and the scientists who worked ... the science of microbiology. A ceremony unveiling ... scheduled for Saturday, June 22, 2013, at 4:30 ...

Breaking Biology News(10 mins):UMass Amherst researchers develop powerful new technique to study protein function 2 UMass Amherst researchers develop powerful new technique to study protein function 3 Microbial diversity course designated as a 'Milestones in Microbiology' site 2

[0] UMass Amherst researchers develop powerful new technique to study protein function [0] PETA International Science Consortium disappointed in denial of Dow appeal [0] Microbial diversity course designated as a 'Milestones in Microbiology' site

... Nov. 17, 2011 Life Technologies Corporation ... that the company has introduced its GeneArt® Algae ... and expression systems for photosynthetic microalgae Chlamydomonas ... strains are model organisms for the study of ...

... -- Researchers have demonstrated that the employees at ... fruits and vegetables and get 50 percent more exercise ... participating in the WellSteps Turnkey Wellness Solution ... and sleep quality. Employees also demonstrated fewer hospital and ...

... might be considered a "performance enhancing" substance for athletes, ... Journal ( http://www.fasebj.org ) shows that these enhancements ... in the brain. According to the study, short- ... constricting arteries, which reduces the flow of blood to ...

Cached Biology News:GeneArt® Algae Engineering Kits by Life Technologies™ 2 GeneArt® Algae Engineering Kits by Life Technologies™ 3 New Study Shows Impact of Employee Wellness Efforts 2 Biker's warning! EPO hits blood vessels to raise blood pressure in the brain 2

GeneArt® Algae Engineering Kits by Life Technologies™New Study Shows Impact of Employee Wellness Efforts Biker's warning! EPO hits blood vessels to raise blood pressure in the brain

... Goat Immunogen: Goats were ... Antibody was isolated by affinity chromatography ... Goat anti- human T7 affinity purified antibodies ... bromide method. Specificity: ...

Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....

Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...

LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...

Biology Products:

Goat Anti-T7 Polyclonal Antibody, Agarose Conjugated from GeneTex Anti-Varicella-zoster Virus, Nucleocapsid Protein Monoclonal Antibody, Unconjugated from CHEMICON Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from Abcam Anti-Echovirus LIGHT DIAGNOSTICS Antibody, Unconjugated from CHEMICON